Oxbow Advisors’s Unilever UL Stock Holding History

Oxbow Advisors’s Portfolio UL Stock Details UL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$945K	Hold	15,716	–	–	0.08%	151
2026 Q1	$895K	Sell	15,716 -101,185	-87%	-$6.78M	0.08%	142
2025 Q4	$7.65M	Sell	116,901 -5,539	-5%	-$372K	0.67%	34
2025 Q3	$8.17M	Buy	122,440 +1,901	+2%	+$131K	0.76%	27
2025 Q2	$8.3M	Buy	120,539 +1,517	+1%	+$106K	0.91%	24
2025 Q1	$7.97M	Buy	119,022 +1,888	+2%	+$122K	0.84%	27
2024 Q4	$7.47M	Buy	117,134 +4,817	+4%	+$325K	0.88%	29
2024 Q3	$8.21M	Buy	112,317 +630	+0.6%	+$43.5K	0.81%	31
2024 Q2	$6.91M	Sell	111,687 -489	-0.4%	-$28.9K	0.81%	32
2024 Q1	$6.33M	Sell	112,176 -443	-0.4%	-$24.5K	0.87%	34
2023 Q4	$6.14M	Buy	112,619 +81,391	+261%	+$4.39M	0.93%	28
2023 Q3	$1.74M	Sell	31,228 -53,568	-63%	-$3.1M	0.27%	56
2023 Q2	$4.97M	Sell	84,796 -136	-0.2%	-$8.08K	0.78%	33
2023 Q1	$4.96M	Sell	84,932 -3,444	-4%	-$196K	0.89%	34
2022 Q4	$5.01M	Buy	88,376 +432	+0.5%	+$23.1K	0.94%	33
2022 Q3	$4.34M	Buy	87,944 +182	+0.2%	+$9.51K	0.68%	39
2022 Q2	$4.53M	Buy	87,762 +3,383	+4%	+$172K	0.64%	43
2022 Q1	$4.33M	Sell	84,379 -159,962	-65%	-$8.9M	0.43%	52
2021 Q4	$14.8M	Buy	244,341 +89,724	+58%	+$5.33M	1.42%	19
2021 Q3	$9.43M	Buy	154,617 +9,074	+6%	+$578K	0.96%	36
2021 Q2	$9.58M	Sell	145,543 -208,572	-59%	-$13.9M	1%	35
2021 Q1	$22.2M	Buy	354,115 +10,855	+3%	+$691K	2.71%	4
2020 Q4	$23.3M	Buy	343,260 +130,483	+61%	+$8.85M	2.98%	4
2020 Q3	$14.8M	Sell	212,777 -5,299	-2%	-$354K	1.87%	8
2020 Q2	$13.5M	Buy	218,076 +207,556	+1,973%	+$12.4M	1.96%	8
2020 Q1	$598K	Hold	10,520	–	–	0.1%	160
2019 Q4	$677K	Hold	10,520	–	–	0.08%	178
2019 Q3	$711K	Hold	10,520	–	–	0.09%	169
2019 Q2	$733K	Hold	10,520	–	–	0.09%	177
2019 Q1	$683K	Hold	10,520	–	–	0.08%	180
2018 Q4	$618K	Hold	10,520	–	–	0.08%	178
2018 Q3	$651K	Hold	10,520	–	–	0.08%	183
2018 Q2	$654K	Hold	10,520	–	–	0.08%	175
2018 Q1	$658K	Hold	10,520	–	–	0.13%	132
2017 Q4	$655K	Hold	10,520	–	–	0.12%	149
2017 Q3	$686K	Hold	10,520	–	–	0.13%	143
2017 Q2	$641K	Hold	10,520	–	–	0.11%	155
2017 Q1	$584K	Hold	10,520	–	–	0.09%	160
2016 Q4	$482K	Hold	10,520	–	–	0.06%	181
2016 Q3	$562K	Hold	10,520	–	–	0.08%	158
2016 Q2	$568K	Hold	10,520	–	–	0.08%	158
2016 Q1	$534K	Hold	10,520	–	–	0.08%	163
2015 Q4	$510K	Hold	10,520	–	–	0.06%	174
2015 Q3	$483K	Hold	10,520	–	–	0.08%	165
2015 Q2	$508K	Buy	+10,520	New	+$520K	0.07%	174

Other funds holding UL

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Oxbow Advisors's UL Position: Q2 2026 in Review

Oxbow Advisors held its Unilever (UL) position steady in Q2 2026 at 15,716 shares worth $945K. The position accounts for 0.08% of the portfolio, ranked #151.

Oxbow Advisors first reported a position in UL in Q2 2015 and has held it in 45 quarters since. The position peaked at $23.3M in Q4 2020. 1,187 funds tracked by Wall St. Rank hold UL as of Q2 2026.

Oxbow Advisors held 15,716 shares of Unilever worth $945K as of Q2 2026.
Oxbow Advisors left its Unilever share count unchanged in Q2 2026.
Unilever made up 0.08% of Oxbow Advisors's portfolio in Q2 2026, its #151 holding.
Oxbow Advisors first reported a position in Unilever in Q2 2015 and has held it in 45 quarters since.
Oxbow Advisors's Unilever position peaked at $23.3M in Q4 2020.
1,187 funds tracked by Wall St. Rank held Unilever as of Q2 2026.

Based on Oxbow Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.